Alphagen arranges $526,500 private placement

Executive Summary

• Alphagen Intelligence Corp. has arranged a non-brokered private placement financing with gross proceeds ranging from $300,000 to $526,500.
• The offering consists of up to 3.9 million units priced at 13.5 cents per unit, with net proceeds designated for general administrative expenditures and working capital.
• Each unit includes one common share and one share purchase warrant exercisable at 18 cents per share for 24 months, subject to a 60-day hold period.

Key Details

• Transaction Structure: Non-brokered private placement financing.
• Units Offered: Minimum of 2,222,222 units; Maximum of 3,900,000 units.
• Price Per Unit: 13.5 cents CAD.
• Gross Proceeds: Minimum of $300,000; Maximum of $526,500.
• Warrant Terms: Each unit comprises one common share and one share purchase warrant.
  • Exercise Price: 18 cents per share.
  • Duration: 24 months from closing.
  • Hold Period: 60 days.
• Use of Proceeds: General administrative expenditures and general working capital purposes.
• Closing Date: Anticipated on or about November 8, 2025, subject to regulatory approvals.
• Regulatory Exemption: Listed Issuer Financing Exemption (LIFE) under Part 5A of National Instrument 45-106 and Coordinated Blanket Order 45-935.
• Resale Restrictions: Securities issued under the LIFE are not subject to resale restrictions under applicable Canadian securities laws.
• Jurisdiction: Offered to purchasers resident in all Canadian provinces except Quebec.
• Offering Document: Dated September 25, 2025, available on SEDAR+ and the company website.